Cyclis Pharmaceuticals, created in 2001 (United States), from 402 sister brands and 17477 competing brands. Cyclis Pharmaceuticals is a brand of Merck & Co, listed on the stock exchange of New York. The sector of Cyclis Pharmaceuticals is Drug Manufacturers.

Cyclis Pharmaceuticals is a brand of Merck & Co (MRK) Share price

Date created : 2001 Business sector Drug Manufacturers

Share price and profitability of the share Merck & Co (Cyclis Pharmaceuticals)

Buy Merck & Co share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 126.19

Portfolio valuation
Merck & Co (Cyclis Pharmaceuticals) over 5 years* USD 224.06

Stock market history Merck & Co (Cyclis Pharmaceuticals)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Merck & Co

VelosBio
VelosBio
ArQule
ArQule
ConnectMed
ConnectMed
Cubist Pharmaceuticals
Cubist Pharmaceuticals
Antelliq
Antelliq
Merck & Co
Merck & Co
See more brands of Merck & Co

Rival brands
Cyclis Pharmaceuticals

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS